- NASDAQ:MRNA most of the people are familiar with the vaccine stocks from pandemic fiasco. - This company is beaten down to the ground and has low market cap as compared to other biopharma stocks. - 2025 would be easier for merger and acquisition which will be good for moderna as it might get acquired by other biopharma companies to accelerate their...
- NASDAQ:MRNA had one of the worst year in 2024. However, cash position is underestimated and the market cap has gotten very low for a company which has proven it's excellence in manufacturing drug and research. - NASDAQ:MRNA is working on cancer prevention vaccines which might get approvals in 2026 which will be a huge propeller for the stock long term....
- Fundamentals are improving, people shorted it because they thought pandemic boosts virtual care but there will always be demand for virtual care & reference when it comes to getting medicine. - There's huge shortage of doctors and wait times at hospital is awful. - This stock is getting accumulated by whales. I believe longer the base, higher in space. PT 1:...
- For NYSE:NKE longs, they gotta feel 10-15% more downside for potential bottom. $63 is the 200 SMA on monthly scale where it could potentially bottom. - Ideally, NYSE:NKE has been losing market share to NYSE:ONON , deckers etc. On top of that there's zero innovation in the shoes and design. Premium price for Nike seems unjustified. - Fair value based on...
- NASDAQ:CFLT has been range bound for two years now where the lower end is $14-18 and upper range is $35-38. - If FY 2025, Q1 exceeds expectation of the analyst then this stock will be able to get through the long term resistance and turn it into support. - NYSE:IOT is a peer company which operates in IOT and streaming data application layer which has...
- NASDAQ:DLTR is a nice turn around story for 2025. It is showing great strength when the market is red. - Any fear around recession will skyrocket this stock. This is by far one of the best risk/reward setup which provide gains when the market is red or is going under correction of some sort. - It's a better buy than its peer NYSE:DG as headwinds for ...
- Lot of work required to break long term downtrend and continue the move up in 200+ - Medium term target before earnings around 150-155 - Solid earning will push the stock price to retest 175-185 range and potentially allow stock to trade above 200s. - Bad earning will move NYSE:SNOW to test the lower end of the trendline i.e low 100s and potentially double...
- Price is overextended and investors are treating NASDAQ:COST as the growth stock than a safe quality stock. Price/Earnings ratio is around 60 which his historical high on the other hand the company is growing single digits. - With wage growth stalling and with uncertain macro, it's unlikely that majority of people will stock groceries for a month in advanced....
- NASDAQ:AMD is one of the beaten down names. It's not too cheap at the current valuation but it's growth for upcoming 2-3 years are promising which deserves a higher multiple. - 25%+ growth rate when revenue is in billions is a big deal unlike NASDAQ:PLTR which has high 20s % growth rate on a revenue of 250 mil a quarter. - Technical supports strong...
- This stock has been beaten down as it failed to reach the masses. - However, the cars are impressive in terms of technology and looks. - Tesla model 3 & Y looks ugly in front of stylish Lucid motor's cars. - A big reason why Lucid might have a good run way to go higher is because of Saudi funding. They have invested billions in this company and would be...
- This is a shipping company in Israel whose fundamentals are getting stronger. - It has 3500+ employees as per linkedin. - It's trading at P/E of 1.82 - Stock based compensation isn't the issue has outstanding shares have remained stable for last 4 years. - Trump in office will lead to stability in the middle east and high probability of negotiation and...
- Ignore FUD, accumulate like the whales 🐋 - Zeta Global Holdings Corp. (NYSE: ZETA) reported robust financial performance in the third quarter of 2024, with revenue reaching $268 million—a 42% year-over-year increase. STOCK TARGET ADVISOR - This growth underscores the company's strong market position and effective strategic initiatives. - Analysts have...
- Ugly draw downs for NASDAQ:PLTR next year. - Fundamentals don't support the rosy valuation. Stock is priced more than perfection. - Investors expectations are way to high and will met with disappointment in upcoming quarters in FY 2025 - FY 2025 will likely trap bulls and lead to severe corrections at much lower levels than Twitter bulls claiming PLTR to the moon 100+
- In the short term, NYSE:UBER price can go down to test $47 at 200 SMA on weekly timeframe. - This will present a solid opportunity to buyer Uber at an attractive valuation. Risks & Opportunities: - Many investors are selling it because of AV i.e waymo & robotaxi by tesla. - These AVs are not a risk for at least 3-5 years. On top of that, Uber is a global...
- NASDAQ:CELH seems to be bottoming out and ready to rip higher. - Haven't looked into fundamentals but technical setup looks lucrative for FY 2025 first half of the year. - Have tried this drink in the stores and it seems to be targeting nice niche who are sugar conscious but want to enjoy a drink to relax without messing up their health.
- Looking at the higher timeframe @ Monthly - It seems like NYSE:NKE is under corrective wave (4) and looking for the bottom. - It appears that Nike has already bottomed around 70s if not this might bottom around $63 which aligns with 200 SMA on a monthly timeframe. - This is one of the safest long setup I have screened so far which can return 100% by end of...
- NVDA has completed it's motive wave 1-5 and currently is under corrective wave ABC. - Within ABC leg, it's under the leg C where it will eventually find a bottom and then start fresh motive wave 1-5. - Chart looks interesting and monitor carefully for the entry when it corrects!
- Whenever NASDAQ:ASML weekly chart touches 200 SMA, it tends to retrace up to 100% from that low. - This company has huge moat and beaten down because of tariff fears.